MHRA has issued updated guidance on the regulation of drugs and devices in the UK (GB and NI) following the end of the Brexit Transition Period (31 December 2020). The…
Woodley BioReg Limited are Regulatory and Quality
experts to the healthcare industry
Woodley BioReg helps pharmaceutical, biopharmaceutical, healthcare, active pharmaceutical ingredient manufacturers and medical device companies develop and manufacture quality products that are effective and safe for patients worldwide.
We provide high quality scientific advice and consulting services in Regulatory Affairs, Quality, and Project Management for all stages of product development, acting as the link between the global Boards of Health/Regulatory Agencies and healthcare product suppliers and manufacturers.
Our core values are the things that clients have told us matter most to them: a superior quality service, value-adding support, our knowledge and extensive experience of the industry, as well as our professionalism and attention to detail in everything that we do.